e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Cystic fibrosis lung disease: what do we measure? What do we know?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Daytime predictors of nocturnal hypoventilation in children with cystic fibrosis
G. Aubertin, M. Boule, M. C. La Rocca, A. Clement, B. Fauroux (Paris, France)
Source:
Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Session:
Cystic fibrosis lung disease: what do we measure? What do we know?
Session type:
Electronic Poster Discussion
Number:
354
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Aubertin, M. Boule, M. C. La Rocca, A. Clement, B. Fauroux (Paris, France). Daytime predictors of nocturnal hypoventilation in children with cystic fibrosis. Eur Respir J 2007; 30: Suppl. 51, 354
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Obstructive sleep apnea and nocturnal hypoventilation in adults and children with cystic fibrosis
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Measures of nocturnal oxyhemoglobin desaturation in children with obstructive lung disease or sleep-disordered breathing
Source: International Congress 2018 – Improvements in the assessment of paediatric physiology
Year: 2018
Sleep hypoxemia in cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 619s
Year: 2005
Sleep quality and daytime function in adults with cystic fibrosis and severe lung disease
Source: Eur Respir J 2002; 19: 504-510
Year: 2002
Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 574s
Year: 2002
Correlations between severity of nocturnal hypoxemia and level of Galectin-3 in obstructive sleep apnea patients
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019
Sleep-related breathing disturbances in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond
Year: 2021
Obesity and daytime somnolence at patients with obstructive sleep apnea and sistemic hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 562s
Year: 2002
Predictors of nocturnal desaturation in COPD patients with mild daytime hypoxaemia
Source: Eur Respir J 2003; 22: Suppl. 45, 468s
Year: 2003
Correlation between intermittent nocturnal hypercapnia and depressive symptoms in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Early onset of sleep-disordered breathing in patients with cystic fibrosis
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010
Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006
CPAP therapy in idiopathic pulmonary fibrosis patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
OSA syndrome in children
Source: Eur Respir Mon 2010; 50: 104-120
Year: 2010
Albuminuria in children with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Pericardial effusion in patients with obstructive sleep apnea syndrome without daily hypoxemia and pulmonary arterial hypertension
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016
Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
The prevalance of bronchial hyperreactivity in patients with habitual snoring and obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 495s
Year: 2002
Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 493s
Year: 2002
Severity of sleep-disordered breathing is an independent predictor of metabolic dysfunction in a population with obstructive sleep apnoea
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept